Case reports of synthetic cannabinoid XLR-11 associated fatalities

Forensic Science International

Volumn 252, Issue , 2015, Pages e6-e9

  Shanks, Kevin G ^a   Winston, David ^b   Heidingsfelder, John ^c   Behonick, George ^a  

^a AIT Laboratories   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c Fayette County Coroner's Office   (United States)

Author keywords

Death; Fatality; LC MS MS; Synthetic cannabinoid; XLR 11

Indexed keywords

ACETIC ACID ETHYL ESTER; CAFFEINE; CANNABINOID; DIPHENHYDRAMINE; HEXANE; NALOXONE; UNCLASSIFIED DRUG; [(1 PENTYL 1H INDOL 3YL)(2,2,3,3 TETRAMETHYLCYCLOPROPYL)METHANONE]; XLR-11;

ADULT; ARTICLE; AUTOPSY; BLOOD SAMPLING; CASE REPORT; CAUSE OF DEATH; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; CONTROLLED STUDY; FATALITY; FEMALE; FORENSIC IDENTIFICATION; FORENSIC TOXICOLOGY; HUMAN; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; PH MEASUREMENT; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; BLOOD;

ADULT; CANNABINOIDS; CHROMATOGRAPHY, LIQUID; FEMALE; FORENSIC TOXICOLOGY; HUMANS; TANDEM MASS SPECTROMETRY;

EID: 84937976710     PISSN: 03790738     EISSN: 18726283     Source Type: Journal    
DOI: 10.1016/j.forsciint.2015.04.021     Document Type: Article

References (15)

1. Pace J.M., Tietje K., Dart M.J., Meyer M.D. 3-Cycloalkylcarbonyl Indoles as Cannabinoid Receptor Ligands 2006, Abbott Laboratories, WO Application 2006069196.
2. Frost J.M., Dart M.J., Tietje K.R., Garrison T.R., Grayson G.K., Daza A.V., El-Kouhen O.F., Miller L.N., Li L., Yao B.B., Hsieh G.C., Pai M., Zhu C.Z., Chandran P., Meyer M.D. Indol-3-yltetramethylcyclopropyl ketones: effects of indole ring substitution on CB2 cannabinoid receptor activity. J. Med. Chem. 2008, 51:1904-1912.
3. Frost J.M., Dart M.J., Tietje K.R., Garrison T.R., Grayson G.K., Daza A.V., El-Kouhen O.F., Yao B.B., Hsieh G.C., Pai M., Zhu C.Z., Chandran P., Meyer M.D. Indol-3-ylcycloalkyl ketones: effects of N1 substituted indole side chain variations on CB(2) cannabinoid receptor activity. J. Med. Chem. 2010, 53:295-315.
4. Wiley J.L., Marusich J.A., Lefever T.W., Grabenauer M., Moore K.N., Thomas B.F. Cannabinoids in disguise: δ9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles. Neuropharmacology 2013, 75:145-154.
5. Uchiyama N., Kawamura M., Kikura-Hanajiri R., Goda Y. URB-754: a new class of designer drug and 12 synthetic cannabinoids detected in illegal products. Forensic Sci. Int. 2013, 227:21-32.
6. Drug Enforcement Administration Establishment of Drug Codes for 26 Substances 2013, vol. 78(3). Federal Register.
7. Shanks K.G., Behonick G.S., Dahn T., Terrell A. Identification of novel third-generation synthetic cannabinoids in products by ultra-performance liquid chromatography and time-of-flight mass spectrometry. J. Anal. Toxicol. 2013, 37:517-525.
8. Drug Enforcement Administration Schedules of Controlled Substances: Temporary Placement of Three Synthetic Cannabinoids into Schedule I 2013, vol. 78(71). Federal Register.
9. Behonick G., Shanks K.G., Firchau D.J., Mathur G., Lynch C.E., Nashelsky M., Jaskierny D.J., Meroueh C. Four postmortem case reports with quantitative detection of the synthetic cannabinoid 5F-PB-22. J. Anal. Toxicol. 2014, 38:559-562.
10. Shanks K.G., Dahn T., Terrell A. Detection of JWH-018 and JWH-073 by UPLC-MS-MS in postmortem whole blood casework. J. Anal. Toxicol. 2012, 36:145-152.
11. Kronstrand R., Roman M., Andersson M., Eklund A. Toxicological findings of synthetic cannabinoids in recreational users. J. Anal. Toxicol. 2013, 37:534-541.
12. Centers for Disease Control and Prevention (CDC) Acute kidney injury associated with synthetic cannabinoid use - multiple states, 2012. MMWR Morb. Mortal. Wkly. Rep. 2013, 62:93-98.
13. Thornton S.L., Wood C., Friesen M.W., Gerona R.R. Synthetic cannabinoid use associated with acute kidney injury. Clin. Toxicol. (Philadelphia) 2013, 51:189-190.
14. Lemos N.P. Driving under the influence of synthetic cannabinoid receptor agonist XLR-11. J. Forensic Sci. 2014, 59:1679-1683.
15. Louis A., Peterson B.L., Couper F.J. XLR-11 and UR-144 in Washington state and state of Alaska driving cases. J. Anal. Toxicol. 2014, 38:563-568.